SJS/TEN or Other Cutaneous Adverse Eevents Induced by Immune Checkpoint Inhibitors (ICIs) vs. Non-ICIs

NCT06522048 · clinicaltrials.gov ↗

COMPLETED

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Immune Checkpoint Inhibitor-Induced Dermatitis
Stevens-Johnson Syndrome, Drug-Induced
Toxic Epidermal Necrolysis Due to Drug

Interventions

OTHER: Observational studies do not require intervention

Sponsor

Chao Ji